[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 11 of about 11
1. Alsaad KO, Obaidat NA, Ghazarian D: Skin adnexal neoplasms--part 1: an approach to tumours of the pilosebaceous unit. J Clin Pathol; 2007 Feb;60(2):129-44
MedlinePlus Health Information. consumer health - Skin Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Skin adnexal neoplasms--part 1: an approach to tumours of the pilosebaceous unit.
  • Skin adnexal neoplasms comprise a wide spectrum of benign and malignant tumours that exhibit morphological differentiation towards one or more types of adnexal structures found in normal skin.
  • Most adnexal neoplasms are relatively uncommonly encountered in routine practice, and pathologists can recognise a limited number of frequently encountered tumours.
  • In this review, the first of two, the normal histology of the skin adnexal structures is reviewed, and the histological features of selected but important benign and malignant tumours and tumour-like lesions of pilosebaceous origin discussed, with emphasis on the diagnostic approach and pitfalls in histological diagnosis.
  • [MeSH-major] Neoplasms, Adnexal and Skin Appendage / pathology. Skin Neoplasms / pathology
  • [MeSH-minor] Humans. Neoplasms, Basal Cell / pathology. Sebaceous Gland Neoplasms / pathology. Skin / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Acta Derm Venereol. 1995 May;75(3):187-9 [7653177.001]
  • [Cites] Int J Dermatol. 1995 Nov;34(11):782-5 [8543411.001]
  • [Cites] J Cutan Pathol. 1995 Oct;22(5):422-6 [8594074.001]
  • [Cites] J Invest Dermatol. 1996 Jul;107(1):41-3 [8752837.001]
  • [Cites] Am J Dermatopathol. 1996 Apr;18(2):218-9 [8740001.001]
  • [Cites] Am J Dermatopathol. 1996 Jun;18(3):296-301 [8806965.001]
  • [Cites] J Dermatol. 1996 Nov;23(11):821-4 [8990706.001]
  • [Cites] Br J Dermatol. 1997 Jan;136(1):30-4 [9039291.001]
  • [Cites] APMIS. 1997 Jan;105(1):35-40 [9063499.001]
  • [Cites] Am J Dermatopathol. 1998 Apr;20(2):140-2 [9557781.001]
  • [Cites] Lupus. 1998;7(3):207-9 [9607646.001]
  • [Cites] Pathology. 1998 May;30(2):212-4 [9643508.001]
  • [Cites] J Cutan Pathol. 1998 Sep;25(8):435-9 [9826169.001]
  • [Cites] Am J Dermatopathol. 1999 Feb;21(1):8-15 [10027518.001]
  • [Cites] Br J Dermatol. 1999 Jan;140(1):8-16 [10215762.001]
  • [Cites] Acta Ophthalmol Scand. 2003 Oct;81(5):536-8 [14510806.001]
  • [Cites] Eur J Dermatol. 2003 Sep-Oct;13(5):487-9 [14693496.001]
  • [Cites] J Cutan Pathol. 2004 Apr;31(4):330-5 [15005691.001]
  • [Cites] Hum Mutat. 2004 Apr;23(4):400 [15024746.001]
  • [Cites] J Invest Dermatol. 2004 Mar;122(3):658-64 [15086550.001]
  • [Cites] Am J Dermatopathol. 2004 Aug;26(4):298-303 [15249860.001]
  • [Cites] Semin Cutan Med Surg. 2004 Jun;23(2):145-57 [15295924.001]
  • [Cites] J Cutan Pathol. 2005 Aug;32(7):491-5 [16008693.001]
  • [Cites] J Cutan Pathol. 2005 Aug;32(7):496-501 [16008694.001]
  • [Cites] Int J Dermatol. 2005 Aug;44(8):668-73 [16101870.001]
  • [Cites] Clin Exp Dermatol. 2006 Jan;31(1):68-70 [16309487.001]
  • [Cites] Lancet Oncol. 2005 Dec;6(12):980-7 [16321766.001]
  • [Cites] J Dermatol Sci. 2006 Jan;41(1):67-75 [16378715.001]
  • [Cites] J Cutan Pathol. 2006 Feb;33(2):123-8 [16420307.001]
  • [Cites] Cancer Res. 1999 Apr 15;59(8):1834-6 [10213487.001]
  • [Cites] Am J Dermatopathol. 1999 Oct;21(5):426-31 [10535570.001]
  • [Cites] Dermatology. 1999;199(4):338-40 [10640845.001]
  • [Cites] J Am Acad Dermatol. 2000 Feb;42(2 Pt 1):263-8 [10642683.001]
  • [Cites] Am J Dermatopathol. 2000 Apr;22(2):108-18 [10770429.001]
  • [Cites] Am J Dermatopathol. 2000 Apr;22(2):183-7 [10770443.001]
  • [Cites] Eur J Dermatol. 1999 Jul-Aug;9(5):363-5 [10417438.001]
  • [Cites] Br J Plast Surg. 1999 Mar;52(2):143-5 [10434894.001]
  • [Cites] Am J Dermatopathol. 1999 Aug;21(4):332-6 [10446773.001]
  • [Cites] Eur J Cancer. 1999 Mar;35(3):433-7 [10448295.001]
  • [Cites] Dermatol Surg. 2004 Dec;30(12 Pt 2):1546-9 [15606837.001]
  • [Cites] J Dermatol. 2004 Oct;31(10):824-7 [15672712.001]
  • [Cites] Am J Dermatopathol. 2005 Feb;27(1):9-16 [15677970.001]
  • [Cites] J Dermatol. 2004 Dec;31(12):998-1008 [15801265.001]
  • [Cites] Clin Exp Dermatol. 2005 May;30(3):259-60 [15807685.001]
  • [Cites] J Am Acad Dermatol. 2000 Aug;43(2 Pt 1):189-206 [10906638.001]
  • [Cites] Am J Dermatopathol. 2000 Aug;22(4):311-5 [10949455.001]
  • [Cites] Malays J Pathol. 1999 Dec;21(2):117-21 [11068417.001]
  • [Cites] Ann Dermatol Venereol. 2001 Jan;128(1):35-7 [11226898.001]
  • [Cites] Am J Dermatopathol. 2001 Apr;23(2):90-8 [11285402.001]
  • [Cites] J Am Acad Dermatol. 2001 Dec;45(6):886-91 [11712034.001]
  • [Cites] Pathologe. 2002 Jan;23(1):71-8 [11974506.001]
  • [Cites] Am J Dermatopathol. 2002 Apr;24(2):149-55 [11979076.001]
  • [Cites] Am J Dermatopathol. 2002 Aug;24(4):294-304 [12142607.001]
  • [Cites] Dermatol Surg. 2003 Jan;29(1):105-7 [12534523.001]
  • [Cites] J Am Acad Dermatol. 2003 Mar;48(3):453-5 [12637930.001]
  • [Cites] Am J Dermatopathol. 2003 Apr;25(2):130-7 [12652194.001]
  • [Cites] Dermatology. 2003;207(1):57-60 [12835551.001]
  • [Cites] Dermatol Surg. 2003 Aug;29(8):886-9 [12859397.001]
  • [Cites] J Cutan Pathol. 2003 Sep;30(8):492-8 [12950500.001]
  • [Cites] J Cutan Pathol. 2003 Sep;30(8):499-503 [12950501.001]
  • [Cites] J Cutan Pathol. 2000 Apr;27(4):169-75 [10774937.001]
  • [Cites] Mod Pathol. 2000 Jun;13(6):673-8 [10874673.001]
  • [Cites] J Eur Acad Dermatol Venereol. 2004 Sep;18(5):607-10 [15324407.001]
  • [Cites] Arch Dermatol. 1979 Aug;115(8):1003-4 [464613.001]
  • [Cites] Br J Dermatol. 1979 Jun;100(6):667-73 [465314.001]
  • [Cites] J Cutan Pathol. 1980 Dec;7(6):394-403 [7451702.001]
  • [Cites] Arch Dermatol. 1980 Dec;116(12):1395 [7458368.001]
  • [Cites] Arch Pathol Lab Med. 1984 Oct;108(10):808-10 [6548121.001]
  • [Cites] Arch Dermatol. 1985 Mar;121(3):413-5 [2983619.001]
  • [Cites] Am J Dermatopathol. 1985 Jun;7(3):207-21 [4051130.001]
  • [Cites] J Am Acad Dermatol. 1989 Apr;20(4):537-63 [2654204.001]
  • [Cites] J Cutan Pathol. 1990 Feb;17(1):45-52 [2319039.001]
  • [Cites] Am J Dermatopathol. 1991 Jun;13(3):275-81 [1867358.001]
  • [Cites] Am J Dermatopathol. 1992 Apr;14(2):107-4 [1373583.001]
  • [Cites] Am J Dermatopathol. 1994 Feb;16(1):23-30 [8160927.001]
  • [Cites] Arch Dermatol. 1994 May;130(5):589-92 [7513986.001]
  • [Cites] J Oral Maxillofac Surg. 1994 Sep;52(9):985-6 [8064466.001]
  • [Cites] Arch Dermatol. 1995 Feb;131(2):198-201 [7857118.001]
  • [Cites] Arch Dermatol. 1995 Apr;131(4):454-8 [7726589.001]
  • (PMID = 16882696.001).
  • [ISSN] 0021-9746
  • [Journal-full-title] Journal of clinical pathology
  • [ISO-abbreviation] J. Clin. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] England
  • [Number-of-references] 80
  • [Other-IDs] NLM/ PMC1860623
  •  go-up   go-down


2. Obaidat NA, Alsaad KO, Ghazarian D: Skin adnexal neoplasms--part 2: an approach to tumours of cutaneous sweat glands. J Clin Pathol; 2007 Feb;60(2):145-59

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Skin adnexal neoplasms--part 2: an approach to tumours of cutaneous sweat glands.
  • Tumours of cutaneous sweat glands are uncommon, with a wide histological spectrum, complex classification and many different terms often used to describe the same tumour.
  • In addition to the eccrine and apocrine glands, two other skin sweat glands have recently been described: the apoeccrine and the mammary-like glands of the anogenital area.
  • In this review (the second of two articles on skin adnexal neoplasms), common as well as important benign and malignant lesions of cutaneous sweat glands are described, and a summary for differentiating primary adnexal neoplasms from metastatic carcinoma is outlined, striving to maintain a common and acceptable terminology in this complex subject.
  • Composite/mixed adnexal tumours are also discussed briefly.
  • [MeSH-major] Neoplasms, Adnexal and Skin Appendage / pathology. Sweat Gland Neoplasms / pathology
  • [MeSH-minor] Adenoma, Pleomorphic / pathology. Adenoma, Sweat Gland / pathology. Carcinoma, Skin Appendage / pathology. Humans. Syringoma / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Clin Pathol. 1999 Nov;52(11):829-32 [10690173.001]
  • [Cites] Am J Clin Pathol. 2000 Apr;113(4):572-5 [10761460.001]
  • [Cites] Am J Dermatopathol. 2000 Apr;22(2):97-103 [10770427.001]
  • [Cites] J Cutan Pathol. 2000 Apr;27(4):199-201 [10774942.001]
  • [Cites] Dermatology. 2000;200(3):250-3 [10828636.001]
  • [Cites] Am J Surg Pathol. 2000 Jun;24(6):775-84 [10843279.001]
  • [Cites] Am J Dermatopathol. 1996 Feb;18(1):83-9 [8721597.001]
  • [Cites] Am J Dermatopathol. 1996 Apr;18(2):124-36 [8739986.001]
  • [Cites] Mod Pathol. 1995 Dec;8(9):897-901 [8751328.001]
  • [Cites] J Cutan Pathol. 1996 Dec;23(6):566-70 [9001989.001]
  • [Cites] Pathol Res Pract. 1996 Nov;192(11):1135-9; discussion 1140-1 [9122033.001]
  • [Cites] Am J Dermatopathol. 1997 Apr;19(2):154-61 [9129700.001]
  • [Cites] J Cutan Pathol. 1997 Apr;24(4):256-60 [9138119.001]
  • [Cites] Am J Clin Pathol. 1997 Jul;108(1):6-12 [9208972.001]
  • [Cites] J Cutan Pathol. 1997 Jul;24(6):370-6 [9243365.001]
  • [Cites] Am J Dermatopathol. 1997 Aug;19(4):358-62 [9261470.001]
  • [Cites] Am J Surg Pathol. 1997 Oct;21(10):1178-87 [9331290.001]
  • [Cites] Am J Dermatopathol. 1998 Feb;20(1):35-40 [9504667.001]
  • [Cites] Ir J Med Sci. 1998 Jan-Mar;167(1):26-7 [9540295.001]
  • [Cites] Br J Dermatol. 1998 Apr;138(4):689-91 [9640381.001]
  • [Cites] Am J Surg Pathol. 1998 Sep;22(9):1125-31 [9737246.001]
  • [Cites] Acta Derm Venereol. 1998 Nov;78(6):460-2 [9833049.001]
  • [Cites] Am J Clin Oncol. 1999 Apr;22(2):131-5 [10199445.001]
  • [Cites] J Cutan Pathol. 1999 Apr;26(4):190-6 [10335896.001]
  • [Cites] J Cutan Pathol. 1999 May;26(5):232-41 [10408348.001]
  • [Cites] J Am Acad Dermatol. 1999 Jul;41(1):115-8 [10411423.001]
  • [Cites] Pathol Int. 1999 May;49(5):419-25 [10417685.001]
  • [Cites] Eur J Surg Oncol. 2001 Jun;27(4):431-5 [11417993.001]
  • [Cites] J Eur Acad Dermatol Venereol. 2001 Mar;15(2):147-9 [11495523.001]
  • [Cites] J Clin Pathol. 2001 Sep;54(9):689-92 [11533075.001]
  • [Cites] J Laryngol Otol. 2001 Aug;115(8):673-5 [11535157.001]
  • [Cites] J Am Acad Dermatol. 2001 Nov;45(5):755-9 [11606929.001]
  • [Cites] J Eur Acad Dermatol Venereol. 2001 May;15(3):242-6 [11683289.001]
  • [Cites] Br J Dermatol. 2001 Oct;145(4):653-6 [11703297.001]
  • [Cites] Arch Pathol Lab Med. 2002 May;126(5):591-4 [11958666.001]
  • [Cites] Hum Pathol. 2002 May;33(5):549-54 [12094382.001]
  • [Cites] Am J Dermatopathol. 2002 Oct;24(5):409-13 [12357203.001]
  • [Cites] Br J Dermatol. 2002 Nov;147(5):936-45 [12410704.001]
  • [Cites] Cutis. 2003 Jan;71(1):49-52, 55 [12553630.001]
  • [Cites] J Am Acad Dermatol. 2003 Mar;48(3):453-5 [12637930.001]
  • [Cites] Dermatol Surg. 2000 Jun;26(6):580-3 [10848941.001]
  • [Cites] J Cutan Pathol. 2000 Aug;27(7):367-73 [10917164.001]
  • [Cites] Am J Dermatopathol. 2000 Dec;22(6):524-9 [11190445.001]
  • [Cites] J Cutan Pathol. 2001 Feb;28(2):101-4 [11168759.001]
  • [Cites] J Cutan Pathol. 2001 Feb;28(2):105-8 [11168760.001]
  • [Cites] Arch Pathol Lab Med. 2001 Apr;125(4):498-505 [11260623.001]
  • [Cites] Br J Dermatol. 2001 Mar;144(3):625-7 [11260030.001]
  • [Cites] Am J Dermatopathol. 2001 Apr;23(2):87-9 [11285401.001]
  • [Cites] Am J Dermatopathol. 2001 Apr;23(2):154-7 [11285414.001]
  • [Cites] Am J Surg Pathol. 2001 Jun;25(6):710-20 [11395548.001]
  • [Cites] Am J Dermatopathol. 2006 Apr;28(2):127-33 [16625074.001]
  • [Cites] J Eur Acad Dermatol Venereol. 2006 May;20(5):608-10 [16684297.001]
  • [Cites] Eur J Dermatol. 2006 Sep-Oct;16(5):576-8 [17101482.001]
  • [Cites] J Clin Pathol. 2007 Feb;60(2):129-44 [16882696.001]
  • [Cites] J Clin Pathol. 2007 May;60(5):567-9 [17513517.001]
  • [Cites] Arch Pathol Lab Med. 1991 Dec;115(12):1249-54 [1662944.001]
  • [Cites] Am J Dermatopathol. 1992 Apr;14(2):149-54 [1566975.001]
  • [Cites] Am J Dermatopathol. 1992 Jun;14(3):245-52 [1510222.001]
  • [Cites] Am J Surg Pathol. 1992 Nov;16(11):1085-91 [1335210.001]
  • [Cites] Cancer. 1993 Jan 15;71(2):375-81 [7678545.001]
  • [Cites] J Cutan Pathol. 1993 Feb;20(1):40-3 [7682227.001]
  • [Cites] Am J Dermatopathol. 1993 Apr;15(2):150-5 [8494116.001]
  • [Cites] Cancer. 1993 Sep 1;72(5):1618-23 [7688655.001]
  • [Cites] Am J Dermatopathol. 1993 Oct;15(5):482-7 [8238787.001]
  • [Cites] Am J Dermatopathol. 1994 Feb;16(1):23-30 [8160927.001]
  • [Cites] Am J Dermatopathol. 1994 Feb;16(1):66-72 [7512801.001]
  • [Cites] Int J Gynecol Pathol. 1994 Apr;13(2):150-60 [8005737.001]
  • [Cites] Am J Dermatopathol. 1995 Jun;17(3):249-55 [8599433.001]
  • [Cites] Am J Dermatopathol. 1995 Oct;17(5):499-505 [8599457.001]
  • [Cites] Am J Dermatopathol. 1996 Feb;18(1):73-6 [8721595.001]
  • [Cites] J Cutan Pathol. 2003 Mar;30(3):202-5 [12641781.001]
  • [Cites] Dermatol Surg. 2003 Jul;29(7):790-2 [12828711.001]
  • [Cites] Dermatology. 2003;207(4):395-7 [14657634.001]
  • [Cites] Mod Pathol. 2003 Dec;16(12):1224-31 [14681323.001]
  • [Cites] Eur J Dermatol. 2003 Sep-Oct;13(5):487-9 [14693496.001]
  • [Cites] J Dermatol. 2004 Jan;31(1):32-8 [14739501.001]
  • [Cites] J Cutan Pathol. 2004 Sep;31(8):561-4 [15268713.001]
  • [Cites] Am J Clin Pathol. 1977 Sep;68(3):397-9 [197847.001]
  • [Cites] Cancer. 1978 Feb;41(2):641-7 [204410.001]
  • [Cites] Br J Dermatol. 1980 Oct;103(4):443-8 [6254556.001]
  • [Cites] Arch Dermatol. 1984 Feb;120(2):231-3 [6696477.001]
  • [Cites] J Cutan Pathol. 1984 Oct;11(5):415-20 [6096424.001]
  • [Cites] Am J Surg Pathol. 1985 Sep;9(9):678-83 [2996375.001]
  • [Cites] Br J Dermatol. 1985 Nov;113(5):565-71 [2998432.001]
  • [Cites] J Hand Surg Br. 1986 Feb;11(1):139-43 [3007643.001]
  • [Cites] Am J Dermatopathol. 1986 Feb;8(1):64-72 [3518523.001]
  • [Cites] J Cutan Pathol. 1987 Jun;14(3):129-46 [3301927.001]
  • [Cites] Br J Dermatol. 1988 Apr;118(4):567-77 [2837268.001]
  • [Cites] Am J Dermatopathol. 1988 Feb;10(1):28-35 [2459984.001]
  • [Cites] J Cutan Pathol. 1989 Aug;16(4):230-6 [2551940.001]
  • [Cites] Am J Dermatopathol. 1991 Apr;13(2):162-8 [1709341.001]
  • [Cites] Am J Surg Pathol. 2005 Jun;29(6):764-82 [15897743.001]
  • [Cites] Am J Dermatopathol. 2005 Jun;27(3):185-8 [15900119.001]
  • [Cites] J Clin Pathol. 2005 Jul;58(7):757-61 [15976347.001]
  • [Cites] Histopathology. 2005 Aug;47(2):195-201 [16045781.001]
  • [Cites] Mod Pathol. 2005 Oct;18(10):1283-8 [15920545.001]
  • [Cites] Mod Pathol. 2006 Feb;19 Suppl 2:S93-S126 [16446719.001]
  • [Cites] Mod Pathol. 1999 Aug;12(8):786-93 [10463481.001]
  • [Cites] Am J Dermatopathol. 2004 Dec;26(6):447-51 [15618924.001]
  • [Cites] J Cutan Pathol. 2005 Jan;32(1):50-4 [15660655.001]
  • [Cites] J Clin Pathol. 2005 Feb;58(2):217-9 [15677547.001]
  • [Cites] J Craniofac Surg. 2005 Jan;16(1):53-8 [15699645.001]
  • [Cites] Am J Dermatopathol. 2005 Apr;27(2):102-10 [15798433.001]
  • [Cites] J Am Acad Dermatol. 2000 Feb;42(2 Pt 1):263-8 [10642683.001]
  • (PMID = 16882695.001).
  • [ISSN] 0021-9746
  • [Journal-full-title] Journal of clinical pathology
  • [ISO-abbreviation] J. Clin. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] England
  • [Number-of-references] 110
  • [Other-IDs] NLM/ PMC1860616
  •  go-up   go-down


3. Obaidat NA, Ghazarian DM: A proliferating composite adnexal tumour of the penis: report of the first case. J Clin Pathol; 2007 May;60(5):567-9
MedlinePlus Health Information. consumer health - Skin Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A proliferating composite adnexal tumour of the penis: report of the first case.
  • [MeSH-major] Neoplasms, Adnexal and Skin Appendage / pathology. Penile Neoplasms / pathology. Skin Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Eur J Dermatol. 2003 May-Jun;13(3):271 [12822557.001]
  • [Cites] J Cutan Pathol. 2003 Mar;30(3):206-10 [12641782.001]
  • [Cites] Cutis. 1982 Mar;29(3):290-2, 294 [6279360.001]
  • [Cites] Arch Dermatol. 1984 Feb;120(2):231-3 [6696477.001]
  • [Cites] J Am Acad Dermatol. 1984 Aug;11(2 Pt 2):374-6 [6090513.001]
  • [Cites] Am J Dermatopathol. 1988 Aug;10(4):311-8 [2843062.001]
  • [Cites] J Cutan Pathol. 1989 Aug;16(4):230-6 [2551940.001]
  • [Cites] Int J Dermatol. 1991 Nov;30(11):763-6 [1661711.001]
  • [Cites] Am J Dermatopathol. 1992 Jun;14(3):186-94 [1380780.001]
  • [Cites] Am J Dermatopathol. 1992 Jun;14(3):245-52 [1510222.001]
  • [Cites] Am J Dermatopathol. 1996 Apr;18(2):124-36 [8739986.001]
  • [Cites] Acta Derm Venereol. 1997 May;77(3):242-3 [9188887.001]
  • [Cites] J Cutan Pathol. 2000 Apr;27(4):199-201 [10774942.001]
  • [Cites] Pathology. 2002 Apr;34(2):196-7 [12009106.001]
  • [Cites] Arch Pathol Lab Med. 2004 Oct;128(10):1181-2 [15387697.001]
  • (PMID = 17513517.001).
  • [ISSN] 0021-9746
  • [Journal-full-title] Journal of clinical pathology
  • [ISO-abbreviation] J. Clin. Pathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC1994519
  •  go-up   go-down


Advertisement
4. Krahl D, Sellheyer K: p75 Neurotrophin receptor differentiates between morphoeic basal cell carcinoma and desmoplastic trichoepithelioma: insights into the histogenesis of adnexal tumours based on embryology and hair follicle biology. Br J Dermatol; 2010 Jul;163(1):138-45
MedlinePlus Health Information. consumer health - Skin Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] p75 Neurotrophin receptor differentiates between morphoeic basal cell carcinoma and desmoplastic trichoepithelioma: insights into the histogenesis of adnexal tumours based on embryology and hair follicle biology.
  • BACKGROUND: Tumour development is frequently described in the basic pathology literature as a recapitulation of embryogenesis.
  • However, a link between the embryology of the skin and the histogenesis of adnexal tumours has been largely overlooked.
  • We therefore speculated that it is involved in the histogenesis of follicular adnexal tumours.
  • In contrast, the lack of p75NTR expression in morphoeic basal cell carcinoma favours a concept of this tumour as a more primitive follicular lesion with the characteristics of a carcinoma and not a hamartoma.
  • [MeSH-major] Biomarkers, Tumor / metabolism. Carcinoma, Basal Cell / metabolism. Hair Follicle / metabolism. Neoplasms, Adnexal and Skin Appendage / metabolism. Receptor, Nerve Growth Factor / metabolism. Skin Neoplasms / metabolism
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Diagnosis, Differential. Female. Humans. Male. Merkel Cells / metabolism. Middle Aged. Skin / embryology. Skin / metabolism

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20184585.001).
  • [ISSN] 1365-2133
  • [Journal-full-title] The British journal of dermatology
  • [ISO-abbreviation] Br. J. Dermatol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Receptor, Nerve Growth Factor
  •  go-up   go-down


5. Mitcov M, Scrivener Y, Cribier B: [Desmoplastic trichoepithelioma: a clinicopathological study, including a comparison with morpheiform basal cell carcinoma]. Ann Dermatol Venereol; 2009 Jun-Jul;136(6-7):501-7
MedlinePlus Health Information. consumer health - Skin Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Desmoplastic trichoepithelioma (DTE) is an uncommon form of adnexal tumour that was described for the first time as a separate clinicopathological entity in 1976.
  • We carried out a retrospective histopathological study of a large series of cases of DTE in order to better characterise this tumour and compare it with sclerodermiform basal cell carcinoma (BCC), which is in fact the most common as well as the most complex type of differential diagnosis.
  • A common finding was granulomas with foreign bodies and calcifications.
  • In six cases (8.8%), a tumour combining DTE with an intradermal naevus was observed.
  • There is a significant association with naevus, a singular feature among adnexal tumours.
  • [MeSH-major] Carcinoma, Basal Cell / pathology. Neoplasms, Adnexal and Skin Appendage / pathology. Skin Neoplasms / pathology
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Facial Neoplasms / pathology. Female. Humans. Male. Middle Aged. Retrospective Studies

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19560610.001).
  • [ISSN] 0151-9638
  • [Journal-full-title] Annales de dermatologie et de vénéréologie
  • [ISO-abbreviation] Ann Dermatol Venereol
  • [Language] fre
  • [Publication-type] Comparative Study; English Abstract; Journal Article
  • [Publication-country] France
  •  go-up   go-down


6. Vidal VP, Ortonne N, Schedl A: SOX9 expression is a general marker of basal cell carcinoma and adnexal-related neoplasms. J Cutan Pathol; 2008 Apr;35(4):373-9
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] SOX9 expression is a general marker of basal cell carcinoma and adnexal-related neoplasms.
  • Here we test whether activation of SOX9 is a general feature of BCC, or whether it could be used as a biomarker to better define subtypes of these skin tumors.
  • In addition we investigated SOX9 expression in other skin epidermal tumors.
  • Staining was heterogeneous and could be detected among the basaloid cells of the palisading cell layer as well as in the tumour nest.
  • SOX9 expression was detected in all adnexal tumors analyzed and absent in Bowen's disease and Merkel tumor.
  • CONCLUSIONS: SOX9 expression is a general feature of BCC and adnexal skin neoplasms, suggesting a contribution of SOX9 to the pathogenesis of these tumors.
  • [MeSH-major] Biomarkers, Tumor / metabolism. Carcinoma, Basal Cell / metabolism. High Mobility Group Proteins / metabolism. Neoplasms, Adnexal and Skin Appendage / metabolism. Skin Neoplasms / metabolism. Transcription Factors / metabolism

  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18333897.001).
  • [ISSN] 1600-0560
  • [Journal-full-title] Journal of cutaneous pathology
  • [ISO-abbreviation] J. Cutan. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Denmark
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / High Mobility Group Proteins; 0 / SOX9 Transcription Factor; 0 / SOX9 protein, human; 0 / Transcription Factors
  •  go-up   go-down


7. Hu SC, Lin CL, Tsai KB, Chen GS, Chin YY, Lin CT, Lan CC: Trichoblastoma-like tumour with follicular, matrical and sebaceous differentiation: involvement of hair follicle stem cells? Acta Derm Venereol; 2010 Jul;90(4):436-7
MedlinePlus Health Information. consumer health - Skin Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Trichoblastoma-like tumour with follicular, matrical and sebaceous differentiation: involvement of hair follicle stem cells?
  • [MeSH-major] Cell Differentiation. Hair Follicle / pathology. Head and Neck Neoplasms / pathology. Neoplasms, Adnexal and Skin Appendage / pathology. Neoplastic Stem Cells / pathology. Scalp. Sebaceous Glands / pathology. Skin Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Head and Neck Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20574623.001).
  • [ISSN] 1651-2057
  • [Journal-full-title] Acta dermato-venereologica
  • [ISO-abbreviation] Acta Derm. Venereol.
  • [Language] eng
  • [Publication-type] Case Reports; Letter
  • [Publication-country] Sweden
  •  go-up   go-down


8. Baxi S, Deb S, Weedon D, Baumann K, Poulsen M: Microcystic adnexal carcinoma of the skin: the role of adjuvant radiotherapy. J Med Imaging Radiat Oncol; 2010 Oct;54(5):477-82
MedlinePlus Health Information. consumer health - Skin Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Microcystic adnexal carcinoma of the skin: the role of adjuvant radiotherapy.
  • INTRODUCTION: Microcystic adnexal carcinoma (MAC) is a rare cutaneous tumour where the role of radiotherapy remains undefined.
  • All cases occurred in the head and neck region with mean tumour size of 20.5 mm and mean depth of invasion of 9.9 mm.
  • There was no evidence that radiotherapy can cause aggressive transformation of the tumour.
  • [MeSH-major] Carcinoma, Skin Appendage / radiotherapy. Head and Neck Neoplasms / radiotherapy. Radiotherapy, Adjuvant. Skin Neoplasms / radiotherapy. Sweat Gland Neoplasms / radiotherapy
  • [MeSH-minor] Aged. Aged, 80 and over. Australia. Female. Follow-Up Studies. Humans. Male. Middle Aged. Neoplasm Recurrence, Local. Radiotherapy Dosage. Retrospective Studies. Treatment Outcome

  • Genetic Alliance. consumer health - Microcystic adnexal carcinoma.
  • MedlinePlus Health Information. consumer health - Head and Neck Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] © 2010 The Authors. Journal of Medical Imaging and Radiation Oncology © 2010 The Royal Australian and New Zealand College of Radiologists No claim to original US government works.
  • (PMID = 20958947.001).
  • [ISSN] 1754-9485
  • [Journal-full-title] Journal of medical imaging and radiation oncology
  • [ISO-abbreviation] J Med Imaging Radiat Oncol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Australia
  •  go-up   go-down


9. Fan YS, Carr RA, Sanders DS, Smith AP, Lazar AJ, Calonje E: Characteristic Ber-EP4 and EMA expression in sebaceoma is immunohistochemically distinct from basal cell carcinoma. Histopathology; 2007 Jul;51(1):80-6
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • A single case exhibited focal weak Ber-EP4 staining, predominantly in mature sebocytes and in < 10% of the tumour cells.
  • We reviewed the immunoreactivity of 51 cases of nodular BCCs and found moderate or strong BerEP4 expression in all cases with never less than 20% of the tumour staining.
  • [MeSH-major] Biomarkers, Tumor / metabolism. Carcinoma, Basal Cell / metabolism. Mucin-1 / metabolism. Neoplasms, Adnexal and Skin Appendage / metabolism. Skin Neoplasms / metabolism

  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17593083.001).
  • [ISSN] 0309-0167
  • [Journal-full-title] Histopathology
  • [ISO-abbreviation] Histopathology
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Mucin-1; 0 / human epithelial antigen-125
  •  go-up   go-down


10. Herwig MC, Vogel A, Holz FG, Löffler KU: [Pilomatrixoma of the ocular adnexae: clinical and histologic analysis (13 cases)]. Klin Monbl Augenheilkd; 2009 May;226(5):404-8
MedlinePlus Health Information. consumer health - Skin Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Transliterated title] Pilomatrixom der okulären Adnexe: Klinische und histologische Aufarbeitung von 13 Fällen.
  • BACKGROUND: Pilomatrixoma (calcifying epithelioma of Malherbe) is a rare benign tumour originating from the matrix of the hair root.
  • In this study, we evaluated the clinical and histopathological characteristics of all the respective tumour specimens submitted to our laboratory since 1997.
  • Paraffin sections were stained with H&E and PAS and, in addition, immunohistochemistry was performed using markers for macrophages (CD68), for proliferative activity (Ki67), and for proliferation/apoptosis (CAS/CSE1L).
  • There was no tumour recurrence in any of the cases within the time period presented.
  • All 13 pilomatrixomas demonstrated the characteristic histology with areas of basophilic islands, shadow cells, calcification and a chronic granulomatous inflammation with foreign body giant cells in varying amounts.
  • No correlation was found between any of the histological or immunohistochemical markers and clinical parameters such as size, age and gender of the patient and duration of tumour presence prior to surgery.
  • [MeSH-major] Hair Diseases / pathology. Neoplasms, Adnexal and Skin Appendage / pathology. Pilomatrixoma / pathology. Skin Neoplasms / pathology

  • Genetic Alliance. consumer health - Pilomatrixoma.
  • MedlinePlus Health Information. consumer health - Hair Problems.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19399712.001).
  • [ISSN] 1439-3999
  • [Journal-full-title] Klinische Monatsblätter für Augenheilkunde
  • [ISO-abbreviation] Klin Monbl Augenheilkd
  • [Language] ger
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


11. Adamicová K, Fetisovová Z, Mellová Y, Výbohová D: [Diagnostic procedures in skin adnexal tumours]. Cesk Patol; 2006 Apr;42(2):59-65

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Diagnostic procedures in skin adnexal tumours].
  • From histogenetic, morphologic and immunohistochemical point of view the authors try to make possible algorithms that can be employed in a routine diagnosis of adnexal skin tumours.
  • They stress the importance of knowledge of clinical data necessary for orientation classification of tumour skin lesions after biopsies.
  • [MeSH-major] Neoplasms, Adnexal and Skin Appendage / diagnosis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16715628.001).
  • [ISSN] 1210-7875
  • [Journal-full-title] Československá patologie
  • [ISO-abbreviation] Cesk Patol
  • [Language] slo
  • [Publication-type] English Abstract; Journal Article; Review
  • [Publication-country] Czech Republic
  • [Number-of-references] 33
  •  go-up   go-down






Advertisement